U UNI-QLEAVER
Live / Registered — Registered (as of 20 Oct 2020)
What this means for you
Registered since 20 Oct 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79271602
- Registration number
- 6177161
- Mark type
- Design + words
- Filed
- 02 Sept 2019
- Published for opposition
- 04 Aug 2020
- Registered
- 20 Oct 2020
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science; biological preparations for use in industry and science; Reagents for scientific and research use, Diagnostic preparations for scientific or research use; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers
- Class 005 — Pharmaceuticals: Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; reagents for medical and veterinary uses; pharmaceutical substances being diagnostic, preparations and substances for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents, substances and contrast media for medical and veterinary purposes
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations, reagents and substances, and of diagnostic preparations, reagents and substances; PEGylation pharmaceuticals research services; industrial analysis and industrial research services in the field of pharmaceutical testing; product design, testing and development in the field of medical technology; information and advice regarding the aforementioned services
Owner
- QuiaPEG Pharmaceuticals AB, Uppsala, SE
- QuiaPEG Pharmaceuticals AB, Uppsala, SE
- QuiaPEG Pharmaceuticals AB, Uppsala, SE
Prosecution history
- 20 Oct 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 20 Feb 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 03 Feb 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 03 Feb 2021 — FINAL DISPOSITION PROCESSED
- 20 Jan 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 20 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 04 Aug 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Aug 2020 — PUBLISHED FOR OPPOSITION
- 31 Jul 2020 — NOTIFICATION PROCESSED BY IB
- 15 Jul 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 15 Jul 2020 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 15 Jul 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jul 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Jul 2020 — EXAMINER'S AMENDMENT ENTERED
- 01 Jul 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED